Longevity Leaders World Congress Transparent 140x
Ageing Science  Speakers

All speakers are listed alphabetically

Jean Accius, Senior Vice President, Thought Leadership and International, AARP

Jean Accius

SVP, Thought Leadership & International
AARP
Samuel Agus, CMO, Biophytis

Samuel Agus

CMO
Biophytis
Laurence Barker, Partner and CBO, Dementia Discovery Fund

Laurence Barker

Partner and CBO
Dementia Discovery Fund
Steven Braithwaite, Chief Scientific Officer, Alkahest Inc

Steven Braithwaite

CSO
Alkahest Inc
Christopher Buckley, Director of the Birmingham NIHR Wellcome Trust Clinical Research Facility, University of Birmingham

Christopher Buckley

Director of the Birmingham NIHR Wellcome Trust Clinical Research Facility
University of Birmingham
Judith Campisi, Professor, Buck Institute for Research on Aging

Judith Campisi

Professor
Buck Institute for Research on Aging
Lynne Cox, Associate Professor, University of Oxford

Lynne Cox

Associate Professor
University of Oxford
Nathaniel David, Co-Founder & President, Unity Biotechnology, Inc.

Nathaniel David

Co-Founder & President
Unity Biotechnology
Aubrey de Grey, CSO, SENS Research Foundation

Aubrey de Grey

CSO, SENS Research Foundation
VP of New Technology Discovery, AgeX Therapeutics
Peter de Keizer, Founder, Cleara Biotech

Peter de Keizer

Founder
Cleara Biotech
Laura Deming, Partner, The Longevity Fund

Laura Deming

Partner
The Longevity Fund
Jens Eckstein, Managing Partner, Apollo Health Ventures

Jens Eckstein

Managing Partner
Apollo Ventures
David Glass, Vice President, Research, Regeneron

David Glass

Vice President, Research
Regeneron
John Godfrey, Corporate Affairs Director, Legal & General

John Godfrey

Corporate Affairs Director
Legal & General
Lorna Harries, Professor in Molecular Genetics, University of Exeter

Lorna Harries

Professor in Molecular Genetics
University of Exeter
Jon Houseley, Epigenetics Group Leader, Babraham Institute

Jon Houseley

Epigenetics Group Leader
Babraham Institute
Thomas Hughes, CEO, Navitor Pharmaceuticals

Thomas Hughes

CEO
Navitor Pharmaceuticals
Ruth Itzhaki, Emeritus Professor, University of Manchester

Ruth Itzhaki

Emeritus Professor
University of Manchester
Sibylle Jager, R&D Innovation Manager, L'Oreal

Sibylle Jager

R&D Innovation Manager
L'Oreal
Poly Mamoshina, Head of Biomarker Development, Insilico Medicine

Poly Mamoshina

Head of Biomarker Development
Insilico Medicine
Reenie McCarthy, CEO, Stealth BioTherapeutics

Reenie McCarthy

CEO
Stealth BioTherapeutics
Jim Mellon, Chairman & Co-Founder, Juvenescence

Jim Mellon

Chairman & Co-Founder
Juvenescence
Eric Morgen, CMO & COO, BioAge Labs

Eric Morgen

CMO & COO
BioAge Labs
S. Jay Olshansky 300x

S. Jay Olshansky

Co-Founder & Chief Scientist, Lapetus Solutions
Professor, University of Illinois
James Peyer, CEO, Cambrian Bio

James Peyer

CEO
Cambrian Bio
Marc Ramis Castelltort, CEO, Senolytic Therapeutics

Marc Ramis Castelltort

CEO
Senolytic Therapeutics
Kerry Russell, VP Clinical Development, resTORbio

Kerry Russell

VP Clinical Development
resTORbio
Reason, CEO, Repair Biotechnologies

Reason

CEO
Repair Biotechnologies
Manuel Serrano, ICREA Professor, IRB Barcelona

Manuel Serrano

ICREA Professor
Institute for Research in Biomedicine (IRB Barcelona)
Tea Shavlakadze, Senior Investigator, Novartis Institutes for Biomedical Research

Tea Shavlakadze

Senior Investigator
Novartis Institutes for Biomedical Research
Pol Vandenbroucke CMO Hospital Business Unit Pfizer 300x

Pol Vandenbroucke

CMO Hospital Business Unit
Pfizer
Beverley Vaughan, Programme Director - UK Spine, University of Oxford

Beverley Vaughan

Programme Director - UK Spine
University of Oxford
Michael West, Founder & CEO, AgeX Therapeutics

Michael West

Founder & CEO
AgeX Therapeutics
Sergey Young, Founder, Longevity Vision Fund

Sergey Young

Founder
Longevity Vision Fund
DOWNLOAD BROCHURE